News Health

(MedPage Today) -- A smartphone-delivered digital cognitive behavioral therapy (CBT) intervention improved generalized anxiety disorder symptoms in adults, a randomized ...

Lung Cancer Screening Follow-Up Often Inadequate

(MedPage Today) -- After finding abnormalities on low-dose CT lung cancer screening, many patients don't get the recommended level of ...

Blockbuster Drug Lands First-Line Indication for HER2-Positive Breast Cancer

(MedPage Today) -- The FDA approved trastuzumab deruxtecan (T-DXd; Enhertu) in combination with pertuzumab (Perjeta) for the first-line treatment of ...

Second Oral Antibiotic for Gonorrhea Gets FDA Green Light

(MedPage Today) -- The FDA on Friday announced approval of zoliflodacin (Nuzolvence) as an oral treatment for gonorrhea, a day ...

Women Getting Bad Advice on Cannabis Use in Pregnancy, Study Finds

(MedPage Today) -- While most cannabis retailers recommended women not use blunts or tobacco while pregnant, about one in five ...

Burden of Postpartum Hemorrhage May Be Greater Than Previously Thought

(MedPage Today) -- Rates of postpartum hemorrhage and severe postpartum hemorrhage were markedly higher with the use of objective blood ...

Look to the States to Lead on Public Health

(MedPage Today) -- The scientifically unsound "Make America Healthy Again" (MAHA) initiative is devastating our country's scientific infrastructure, medical research ...

Walking Away With Purpose …

(MedPage Today) -- Editor's Note: This will be David Nash's final "Focus on Policy" column for MedPage Today. Nash has ...

Myeloma Combination Cuts Line for FDA Approval After Strong ASH Results

(MedPage Today) -- Under a program designed to accelerate the approval of products that could address key national priorities, the ...

Akeega Approved for BRCA2-Mutated Prostate Cancer

(MedPage Today) -- The FDA approved niraparib and abiraterone acetate (Akeega) in combination with prednisone for treating BRCA2-mutated metastatic castration-sensitive ...

FDA Approves Uplizna for Generalized Myasthenia Gravis

The B-cell depleting therapy is indicated for adults with generalized myasthenia gravis and anti-acetylcholine receptor or anti-muscle-specific tyrosine kinase antibodies. ...

Etripamil Gets FDA Approval for At-Home Tachycardia Conversion

(MedPage Today) -- The FDA approved etripamil (Cardamyst) nasal spray for at-home treatment of paroxysmal supraventricular tachycardia (PSVT), maker Milestone ...

Novel Pills Promising in Relapsed/Refractory Multiple Myeloma

(MedPage Today) -- All-oral therapies provide an attractive treatment option for patients with relapsed/refractory multiple myeloma, given their administration, the ...

Longevity Forever!

(MedPage Today) -- "So, Dr. Pelzman, can you tell me what I should do about all this stuff?" I've written ...

FDA Approves Niraparib-abiraterone Acetate Combo for CSPC

The treatment combination was previously approved in BRCA2m-positive patients with metastatic castrate-resistant prostate cancer. Medscape Medical News Source link : ...

Outcomes Remain Poor in Blast-Phase CML, Despite Modern TKIs

(MedPage Today) -- At the recent American Society of Hematology annual meeting, researchers presented real-world outcomes for patients with blast-phase ...

‘We don’t blame dad for killing mum, he was ill’